Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quadrate Combination Therapy for Early Breast Cancer
NCT05016349Phase 3Unknown
- Start
- Aug 2021
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of mifepristone, cannabidiol, tretinoin, alitretinoin, isotretinoin in breast cancer. Status: unknown.
02
Drugs
mifepristonecannabidioltretinoinalitretinoinisotretinoin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05016349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05016349.